AR and posterior cortical atrophy: Furthermore, addition of ADT to other systemic agents, such as AR targeted therapy, have recently been noted to improve overall survival in a systematic review when comparing systemic treatments for metastatic castration-sensitive (hormone sensitive) PCa [38].